GO
Loading...

Johnson & Johnson

More

  • J&J withdraws fibroid treatment device from market Wednesday, 30 Jul 2014 | 6:55 PM ET

    WASHINGTON— Johnson& Johnson is asking surgeons not to use a line of devices for removing growths from the uterus amid regulators' growing concern that the electronic surgical tools raise the risk of spreading cancer to other parts of the body. The company cited an FDA meeting earlier this month that reinforced "the complexity of this issue."

  • July 30- Johnson& Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids. The FDA had advised doctors not to use the devices pending further review.

  • Final Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $51.12. Hospira rose $4.31 or 8.3 percent, to $56.21.

  • Final Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Allergan rose $1.27 or. 7 percent, to $172.17. Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Boston Scientific Corp. rose$. 25 or 1.9 percent, to $13.14.

  • Midday Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Allergan rose $1.25 or. 7 percent, to $172.15. Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $13.07.

  • Midday Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Bristol-Myers Squibb Co. fell$. 03 or. 1 percent, to $50.98. Hospira rose $4.08 or 7.9 percent, to $55.98.

  • Early Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Bristol-Myers Squibb Co. fell$. 29 or. 6 percent, to $50.73. Hospira rose $2.11 or 4.1 percent, to $54.01.

  • Early Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Allergan rose $1.15 or. 7 percent, to $172.05. Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Boston Scientific Corp. rose$. 02 or. 2 percent, to $12.91.

  • The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch& Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.

  • The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch+ Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.

  • Final Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell$. 18 or. 2 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.80. Hospira rose$. 12 or. 2 percent, to $51.84.

  • Final Glance: Medical Devices companies Monday, 28 Jul 2014 | 6:04 PM ET

    Allergan rose$. 09 or. 1 percent, to $170.15. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97. Medtronic fell$. 14 or. 2 percent, to $62.76.

  • Midday Glance: Medical Devices companies Monday, 28 Jul 2014 | 1:31 PM ET

    Allergan fell$. 02 or percent, to $170.04. Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Boston Scientific Corp. fell$. 20 or 1.5 percent, to $12.91.

  • Midday Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Bristol-Myers Squibb Co. rose$. 02 or percent, to $49.41. Hospira rose $1.03 or 2.0 percent, to $52.75.

  • Early Glance: Medical Devices companies Monday, 28 Jul 2014 | 10:33 AM ET

    Allergan rose$. 55 or. 3 percent, to $170.61. Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97.

  • Early Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Bristol-Myers Squibb Co. fell$. 21 or. 4 percent, to $49.18. Hospira rose $2.43 or 4.7 percent, to $54.15.

  • Europe backs new leukemia drugs from J&J and Gilead Friday, 25 Jul 2014 | 7:20 AM ET

    LONDON, July 25- Two new leukemia drugs from Johnson& Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The European Medicines Agency said on Friday its experts had issued positive opinions for J&J's ibrutinib, developed with Pharmacyclics, and Gilead's idelalisib.

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Final Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $49.46. Hospira rose $1.16 or 2.3 percent, to $51.82.

  • Midday Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.52. Hospira rose$. 74 or 1.5 percent, to $51.40.